- Home » News and EventsPage 31
NEWS & EVENTS
Our newest offerings and capabilities. Recent investments in network capacity, new and expanded services and expertise. Upcoming conferences and events.
Phase-Appropriate Validation of Bioassays to be Presented at WCBBA
Oct 15, 2018
Catalent Pharma Solutions today announced that one of its scientific experts will host a workshop during KNect365 Life Sciences’ annual Well Characterized Biologics & Biological Assays conference (WCB…
Catalent Completes Tender Offer For All Outstanding Shares Of Juniper Pharmaceuticals, Inc.
Oct 13, 2018
Catalent Completes Tender Offer For All Outstanding Shares Of Juniper Pharmaceuticals, Inc. (NYSE:CTLT) (“Catalent”), the leading global provider of advanced delivery technologies and development solu…
Catalent Clinical Supply Experts Present at Industry Conferences
Oct 11, 2018
Catalent Clinical Supply Experts Present at Industry Conferences. SOMERSET, N.J. – October 11, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and devel…
Catalent Invests $7.3 Million at Aprilia Facility
Oct 4, 2018
SOMERSET, N.J., October 4, 2018 – Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products, …
Catalent to Provide Oral Delivery Systems for Parkinson’s Disease Therapies
Sep 26, 2018
Catalent Pharma Solutions today announced that GB Sciences has selected Catalent to provide oral delivery systems, formulation development, and clinical-scale oral dose manufacturing of GB Sciences’ p…
Lipid-Based Drug Delivery Presented by Catalent and BASF
Sep 20, 2018
Lipid-Based Drug Delivery Presented by Catalent and BASF. SOMERSET, N.J. – September 20, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development…
Aucta Pharmaceuticals Signs Commercial Manufacturing Agreement with Catalent
Sep 4, 2018
Somerset, N.J. – September 4, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health product…
Catalent Experts to Discuss Biologics Development and Manufacturing at BPI East
Aug 30, 2018
SOMERSET, N.J. – August 30, 2018 — Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products,…
Catalent Completes Tender Offer for Juniper Pharmaceuticals, Inc.
Aug 14, 2018
Catalent Completes Tender Offer for Juniper Pharmaceuticals, Inc. (NYSE:CTLT) (“Catalent”), the leading global provider of advanced delivery technologies and development solutions for drugs, biologics…
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.